Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase

Journal of Histochemistry and Cytochemistry

Volumn 51, Issue 6, 2003, Pages 789-796

  Rodrigues Lima, Fernando ^a,b   Cooper, Racquel N ^a   Goudeau, Bertrand ^a   Atmane, Noureddine ^a   Chamagne, Anne Marie ^a   Butler Browne, Gillian ^a   Sim, Edith ^c   Vicart, Patrick ^b   Dupret, Jean Marie ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Human skeletal muscle; Immunohistochemistry; NATs; RT PCR; Western blotting; Xenobiotics

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE 1; ARYLAMINE ACETYLTRANSFERASE 2; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ACETYLATION; ADULT; AGE; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUSCLE BIOPSY; NEWBORN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUADRICEPS FEMORIS MUSCLE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

EID: 0038012890     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540305100610     Document Type: Article

References (47)

1. Atalay M, Seene T, Hanninen O, Sen CK (1996) Skeletal muscle and heart antioxidant defences in response to sprint training. Acta Physiol Scand 158:129-134
2. Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-203
3. Butcher NJ, Ilett KF, Minchin RF (2000a) Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid. Biochem Pharmacol 60:1829-1836
4. Butcher NJ, Ilett KF, Minchin RF (2000b) Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 57:468-473
5. Chowrashi P, Mittal B, Sanger JM, Sanger JW (2002) Amorphin is phosphorylase: phosphorylase is an alpha-actinin-binding protein. Cell Motil Cytoskel 53:125-135
6. Crosbie SJ, Blain PG, Williams FM (1997) An investigation into the role of rat skeletal muscle as a site for xenobiotic metabolism using microsomes and isolated cells. Hum Exp Toxicol 16:138-145
7. Davidson M, Collins M, Byrne J, Vora S (1983) Alterations in phosphofructokinase isoenzymes during early human development. Establishment of adult organ-specific patterns. Biochem J 214:703-710
8. Derewlany LO, Knie B, Koren G (1994) Arylamine N-acetyltransferase activity of the human placenta. J Pharmacol Exp Ther 269:756-760
9. Evans DAP, White TA (1964) Human acetylation polymorphism. J Lab Clin Med 63:394-403
10. Fougerousse F, Edom-Vovard F, Merkulova T, Ott MO, Durand M, Butler-Browne G, Keller A (2002) The muscle-specific enolase is an early marker of human myogenesis. J Muscle Res Cell Motil 22:535-544
11. Fretland AJ, Doll MA, Leff MA, Hein DW (2001a) Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1. Pharmacogenetics 11:511-520
12. Fretland AJ, Leff MA, Doll MA, Hein DW (2001b) Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms. Pharmacogenetics 11:207-215
13. Guengerich FP (1992) Metabolic activation of carcinogens, Pharmacol Ther 54:17-61
14. Hein D (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 65:506-507
15. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina US, et al. (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9:29-42
16. Hickman D, Pope J, Patil SD, Fakis G, Smelt V, Stanley LA, Payton M, et al. (1998) Expression of arylamine N-acetyltransferase in human intestine. Gut 42:402-409
17. Hightower LE (1998) The promise of molecular biomarkers for environmental monitoring. Biol Chem 379:1213-1215
18. Hughes NC, Janezic SA, McQueen KL, Jewett MA, Castranio T, Bell DA, Grant DM (1998) Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 8:55-66
19. Hussey AJ, Kerr LA, Cronshaw AD, Harrison DJ, Hayes JD (1991) Variation in the expression of Mu-class glutathione S-transferase isoenzymes from human skeletal muscle. Evidence for the existence of heterodimers. Biochem J 273:323-332
20. Ilett KF, Ingram DM, Carpenter DS, Teitel CH, Lang NP, Kadlubar FF, Minchin RF (1994) Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem Pharmacol 47:914-917
21. Ip W (1999). Guidebook to the Cytoskeletal and Motor Proteins. Oxford, Oxford University Press
22. Irshaid YM, al-Hadidi HF, Abuirjeie MA, Rawashdeh NM, Gharaibeh NS (1993) Acetylation of dapsone by human whole blood. Int J Clin Pharmacol Ther Toxicol 31:18-22
23. Kawakubo Y, Yamazoe Y, Kato R, Nishikawa T (1990) High capacity of human skin for N-acetylation of arylamines. Skin Pharmacol 3:180-185
24. Khazaeinia T, Ramsey AA, Tam YK (2000) The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci 3:292-302
25. Kondo H, Nakagaki I, Sasaki S, Hori S, Itokawa Y (1993) Mechanism of oxidative stress in skeletal muscle atrophied by immobilization. Am J Physiol 265:E839-844
26. Liu Y, Steinacker JM (2001) Changes in skeletal muscle heat shock proteins: pathological significance. Front Biosci 6:D12-25
27. Matas N, Thygesen P, Stacey M, Risch A, Sim E (1997) Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours. Cytogenet Cell Genet 77:290-295
28. McArdle A, Vasilaki A, Jackson M (2002) Exercise and skeletal muscle ageing: cellular and molecular mechanisms. Ageing Res Rev 1:79-93
29. Meisel P (2002) Arylamine N-acetyltransferases and drug response. Pharmacogenomics 3:349-366
30. Meisel P, Giebel J, Peters M, Foerster K, Cascorbi I, Wulff K, Fanghaenel J, Kocher T (2002) Expression of N-acetyltransferases in periodontal granulation tissue. J Dent Res 81:349-353
31. Meyer DJ, Ketterer B (1995) Purification of soluble human glutathione S-transferases. Methods Enzymol 252:53-65
32. Minchin RF (1995) Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307:1-3
33. Ohsako S, Deguchi T (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 265:4630-4634
34. Pacifici GM, Bencini C, Rane A (1986) Acetyltransferase in humans: development and tissue distribution. Pharmacology 32:283-291
35. Pansarasa O, Bertorelli L, Vecchiet J, Felzani G, Marzatico F (1999) Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. Free Radic Biol Med 27:617-622
36. Ricart E, Taylor WR, Loftus EV, O'Kane D, Weinshilboum RM, Tremaine WJ, Harmsen WS, et al. (2002) N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis. Am J Gastroenterol 97:1763-1768
37. Riggs JE (1998) Alcohol-associated rhabdomyolysis: ethanol induction of cytochrome P450 may potentiate myotoxicity. Clin Neuropharmacol 21:363-364
38. Sadrieh N, Davis CD, Snyderwine EG (1996) N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res 56:2683-2687
39. Sim E, Payton M, Noble M, Minchin R (2000) An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet 9:2435-2441
40. Smelt VA, Upton A, Adjaye J, Payton MA, Boukouvala S, Johnson N, Mardon HJ, et al. (2000) Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet 9:1101-1107
41. Smith C, Stamm SC, Riggs JE, Stauber W, Harsh V, Gannett PM, Hobbs G, et al. (2000) Ethanol-mediated CYP1A1/2 induction in rat skeletal muscle tissue. Exp Mol Pathol 69:223-232
42. Sonawane BR, Lucier GW (1975) Hepatic and extrahepatic N-acetyltransferase. Perinatal development using a new radioassay. Biochim Biophys Acta 411:97-105
43. Stanley LA, Coroneos E, Cuff R, Hickman D, Ward A, Sim E (1996) Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder. J Histochem Cytochem 44:1059-1067
44. Tomarev SI, Piatigorsky J (1996) Lens crystallins of invertebrates diversity and recruitment from detoxification enzymes and novel proteins. Eur J Biochem 235:449-465
45. Upton A, Johnson N, Sandy J, Sim E (2001) Arylamine N-acetyl-transferases - of mice, men and microorganisms. Trends Pharmacol Sci 22:140-146
46. Wang AM, Doyle MV, Mark DF (1989) Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86:9717-9721
47. Windmill KF, Gaedigk A, Hall PM, Samaratunga H, Grant DM, McManus ME (2000) Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci 54:19-29